Clinical Trial

Small RNA tRF-31 Changes in Patients With Age-Related Cataract

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 29, 2026 (before its estimated August 16, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to evaluate the expression characteristics and clinical relevance of the tRF-31/HIPK2 signaling axis in adults over 18 years old with age-related cataract (ARC). The main questions it aims to answer are: Is there a correlation between the relative expression levels of tRF-31 and its target gene HIPK2 in the anterior lens capsule and the clinical severity (Emery-Little grading system) of age-related cataracts? Does oxidative stress in the anterior segment microenvironment have a potential bystander effect on the state of the corneal endothelium? Participants will:Undergo routine preoperative ophthalmologic examinations, including visual acuity tests, slit-lamp photography, and corneal endothelial cell counting. Undergo standard cataract surgery (phacoemulsification combined with intraocular lens implantation) as part of their regular medical care. Allow researchers to collect and analyze their anterior lens capsule tissue, which is routinely removed and typically discarded as medical waste during the standard continuous curvilinear capsulorhexis (CCC) step of the surgery.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT07672899
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions Cataract
Enrollment 200 participants
Start Date 2026-06-17
Primary Completion 2026-08-16 (estimated)
Study Completion 2026-09-16 (estimated)
Updated on ClinicalTrials.gov 2026-06-29